Cargando…

Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy

Detalles Bibliográficos
Autores principales:	Glorieux, Christophe, Cui, Lei, Zeng, Peiting, Xia, Xiaojun, Huang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118588/ https://www.ncbi.nlm.nih.gov/pubmed/33650790 http://dx.doi.org/10.1002/cac2.12139

Ejemplares similares

Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
por: Alliot, C
Publicado: (2004)

Reply: Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer
por: Ohwada, S, et al.
Publicado: (2004)

Wilms’ tumour and chemotherapeutic access
por: Yasri, Sora, et al.
Publicado: (2015)

Oncogenic K-ras Induces Mitochondrial OPA3 Expression to Promote Energy Metabolism in Pancreatic Cancer Cells
por: Meng, Ning, et al.
Publicado: (2019)

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
por: Chen, Yichao, et al.
Publicado: (2016)

The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer
por: Glorieux, Christophe, et al.
Publicado: (2021)

Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents
por: Bojko, Agnieszka, et al.
Publicado: (2019)

Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)

Current trends of anticancer immunochemotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Expanding the role of combined immunochemotherapy and immunoradiotherapy in the management of head and neck cancer (Review)
por: Wei, Chun, et al.
Publicado: (2023)

High expression of neuroguidin increases the sensitivity of acute myeloid leukemia cells to chemotherapeutic drugs
por: Chen, Kejun, et al.
Publicado: (2015)

Chemotherapeutic Effect on Ovarian Stroma and Tumor Cells Which Make Problem in Diagnosis and Staging of Tumor
por: Nasirian, Neda, et al.
Publicado: (2021)

Is CA19-9 effective in predicting chemotherapeutic response in patients with synchronous liver metastases with colorectal cancer?
por: Demirli Atici, Semra, et al.
Publicado: (2022)

Trial Watch: Lenalidomide-based immunochemotherapy
por: Semeraro, Michaela, et al.
Publicado: (2013)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
por: Yadagiri, Ganesh, et al.
Publicado: (2023)

Bifidobacterium in anticancer immunochemotherapy: friend or foe?
por: Procaccianti, Giorgia, et al.
Publicado: (2023)

bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti‐angiogenic agent apatinib combination therapy
por: Xu, Gehan, et al.
Publicado: (2022)

Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy
por: Zeng, Peiting, et al.
Publicado: (2022)

A case report of small cell ovarian neuroendocrine carcinoma combined with immunochemotherapy
por: Zhu, Yuan-Xue, et al.
Publicado: (2022)

Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents
por: Frampton, Gabriel, et al.
Publicado: (2010)

Liposomal Saffron: A Promising Natural Therapeutic and Immune-Boosting Agent
por: Jamalifard, Raziyeh, et al.
Publicado: (2022)

Nobiletin enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cancer cells
por: Ma, Wenzhe, et al.
Publicado: (2015)

Effect of Various Chemotherapeutic Agents on Metastasis
por: Lapis, K., et al.
Publicado: (1956)

Accidental Overdose of Multiple Chemotherapeutic Agents
por: Kim, In Soon, et al.
Publicado: (1989)

Nail Changes Induced by Chemotherapeutic Agents
por: Saraswat, Neerja, et al.
Publicado: (2020)

Anesthesia Medications and Interaction with Chemotherapeutic Agents
por: Watson, Jeremy, et al.
Publicado: (2021)

Dual role for p16 in the metastasis process of HPV positive head and neck cancers
por: Dok, Rüveyda, et al.
Publicado: (2017)

DNA methylation signature predicts cancer response to demethylation agents from profiling diverse cancer cell lines
por: Sun, Zhifu, et al.
Publicado: (2022)

Protective Cellular Immune Response Induction for Cutaneous Leishmaniasis by a New Immunochemotherapy Schedule
por: da Silva, Danielle A. M., et al.
Publicado: (2020)

Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
por: Liu, Chaoyuan, et al.
Publicado: (2023)

Emerging new therapeutic applications of capecitabine as a first-line chemotherapeutic agent in the management of advanced carcinomas other than colorectal carcinoma
por: Kapoor, Shailendra
Publicado: (2012)

Impact of taxane-based chemotherapeutics on male reproductive function
por: Kanodia, Charvi, et al.
Publicado: (2023)

Cell cycle activity correlates with increased anti‐tumor immunity in diverse cancers
por: Jiang, Shanmei, et al.
Publicado: (2020)

The differential roles of zinc in immune responses and their potential implications in antiviral immunity against SARS-CoV-2
por: Reinhold, Dirk, et al.
Publicado: (2021)

Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
por: Xia, Hongping, et al.
Publicado: (2017)

In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
por: Siemann, D. W.
Publicado: (1981)

Bone Marrow Osteoblast Damage by Chemotherapeutic Agents
por: Rellick, Stephanie L., et al.
Publicado: (2012)

Current Research and Development of Chemotherapeutic Agents for Melanoma
por: Hsan, Kyaw Minn, et al.
Publicado: (2010)

Nail Changes With Chemotherapeutic Agents and Targeted Therapies
por: Mittal, Shankila, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9vt6tb91o9hdhe538m2js61u6h